Efficacy and Safety of Zolbetuximab in Gastric Cancer

Oncology (United States) · Published 2024-11-25 · DOI 10.46883/2024.25921031

Authors being retrieved — see the publisher record. https://doi.org/10.46883/2024.25921031

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2024

Related articles

Zolbetuximab-based chemotherapy in CLDN18.2-positive gastric cancer: real-world tumor response and early albumin kinetics · Japanese Journal of Clinical Oncology · 2026 · Cites or is cited by this article
Structure and function of therapeutic antibodies approved by the US FDA in 2024 · Antibody Therapeutics · 2025 · Cites or is cited by this article
A Multicenter Quality Audit Standardizing Esophageal Contouring in Postmastectomy Radiotherapy. · Oncology (United States) · 2026 · Same journal
A Rare Case of Metastatic Spiradenocarcinoma With CDKN2A Mutation · Oncology (United States) · 2024 · Same journal
GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer · Oncology (United States) · 2025 · Same journal
Continued Success of Venetoclax in t(11;14) Multiple Myeloma Despite Negative Trials · Oncology (United States) · 2024 · Same journal
Improving Leukoplakia Follow-Up: Information Leaflets, Habit Cessation Counseling · Oncology (United States) · 2025 · Same journal
Insights, Knowledge Gaps, and Priorities in Marginal Zone Lymphoma Research · Oncology (United States) · 2025 · Same journal
A Phase 2 Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and Neck · Oncology (United States) · 2025 · Same journal
Late Hepatic Recurrence From Granulosa Cell Tumor: A Case Report · Oncology (United States) · 2025 · Same journal